×
Please click
here
if you are not redirected within a few seconds.
All
News
Images
Maps
Videos
Shopping
Books
Search tools
Recent
Recent
Past hour
Past 24 hours
Past week
Past month
Past year
Archives
Sorted by relevance
Sorted by relevance
Sorted by date
InflaRx to Host Virtual R&D Event on June 5, 2024 and Report First Quarter 2024 Results on May 8, 2024
Yahoo Finance Canada
JENA, Germany, April 30, 2024 (GLOBE NEWSWIRE) -- InflaRx N.V. (Nasdaq: IFRX), a biopharmaceutical company pioneering anti-inflammatory...
3 days ago
Raymond James & Associates Acquires 12873 Shares of InflaRx (NASDAQ:IFRX)
Defense World
Raymond James & Associates raised its holdings in InflaRx (NASDAQ:IFRX – Free Report) by 7.9% during the fourth quarter, according to the...
3 days ago
InflaRx (IFRX) Scheduled to Post Earnings on Wednesday
MarketBeat
InflaRx (NASDAQ:IFRX) will be releasing earnings before the market opens on Wednesday, May 8, Zacks reports.
2 days ago
InflaRx Picks Outcomes-Based Reimbursement For COVID-19 Drug
Scrip
The model, more common with high-cost gene therapies, is designed to de-risk use of the drug for hospitals in the event that patients with COVID-19-related...
2 months ago
InflaRx N.V. Announces Share Capital Amendment - TipRanks.com
Tipranks
Inflarx N.V. (IFRX) has released an update. InflaRx N.V., a Dutch-based public limited liability company, has announced a partial amendment...
1 week ago
IFRX Stock Quote Price and Forecast
CNN
InflaRx NV is a clinical-stage biopharmaceutical company, which engages in the discovery and development of inhibitors of the complement activation factor...
2 months ago
InflaRx Announces Initiation of its Commitment Program for GOHIBIC®(vilobelimab) to Help Broaden Access for ...
Yahoo Finance
InflaRx to cover costs of GOHIBIC for patients who are treated in line with its Emergency Use Authorization (EUA) but do not survive.
3 months ago
InflaRx to Participate in Capital One Securities 1st Annual Biotech/Biopharma Disrupters Event
GlobeNewswire
JENA, Germany, April 24, 2024 (GLOBE NEWSWIRE) -- InflaRx N.V. (Nasdaq: IFRX), a biotechnology company pioneering anti-inflammatory...
1 week ago
InflaRx N.V. Announces 2024 AGM Details - TipRanks.com
Tipranks
Inflarx N.V. (IFRX) has released an update. InflaRx N.V. has announced its annual general meeting (AGM) to be held in Amsterdam on April 25,...
1 month ago
Is InflaRx (NASDAQ:IFRX) In A Good Position To Deliver On Growth Plans?
Yahoo Finance
Even though it has reduced its cash burn recently, shareholders should still consider how easy it would be for InflaRx to raise more cash in the...
1 month ago